Environment
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
StateNew HampshireIn Committee
HB 1784: relative to the health care consumer protection trust fund.
Julie Miles
HB 1784 status: In Committee — Subcommittee Work Session: 09/23/2026 10:00 am GP 230 (updated Sep 17, 2026).
Source
LegiScan
Confidence
High
Analysis basis
LegiScan full bill text
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
71OUT OF 100
Score:71/100 civic fit
Risk:Moderate Risk
Impact:Moderate Impact 60/100
Constitutionality95%
Bipartisan70%
Public opinion80%
Bill summary
What changes
The bill updates the administration of the Health Care Consumer Protection Trust Fund by removing Executive Council approval for expenditures, prohibiting the use of funds for academic research, and forbidding grants or contracts to state agencies.
Who is affected
The Department of Justice (increased oversight duties), non-governmental health care providers, and state agencies that previously received funding from this trust.
Requirements and enforcement
Recipients must demonstrate defined, measurable patient-outcome objectives, adhere to milestone-based payment structures, and submit to audit and clawback provisions.
Costs and funding
The DoJ estimates an annual indeterminable fiscal impact between $100,000 and $500,000 for additional staff (Assistant Attorney General and paralegal) to handle the new oversight burden.
When it takes effect
Takes effect 60 days after passage.
Potential benefits
Increases accountability, ensures fund usage is tied directly to clinical outcomes for consumers, and streamlines the approval process by removing the Executive Council.
Risks and tradeoffs
Significant administrative costs, loss of state agency funding access, and the prohibition of academic research which may limit future-oriented public health insights.
What is still unknown
The final volume of grant applications and the extent to which enforcement costs will reduce the total pool of available funding.
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Mixed / Neutral
55%
Benefits
- Increases fiscal rigor through mandatory milestone-based disbursements
- Encourages high-performance contracting
- Directs settlement funds toward direct consumer services rather than institutional overhead
Risks
- Adds significant Department of Justice administrative and staffing costs
- Prohibits state agencies from receiving grants or subgrants
- Imposes high compliance transaction costs on project recipients
Society
Positive outlook
70%
Benefits
- Ensures funds prioritize direct patient health services
- Mandates measurable outcomes to verify social benefit
- Strengthens requirements for community-based interventions
Risks
- Restricts funding for social research that could identify future health needs
- Limits potential for broad population health projects if outcomes are not immediately measurable
- Could reduce overall funding availability if state agencies are barred from serving as intermediaries
Technology Industry
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Civic Accountability
Positive outlook
85%
Benefits
- Eliminates potential for Executive Council political friction in grant awards
- Establishes mandatory audit rights for all expenditures
- Includes clear clawback provisions for non-performance
Risks
- Increases concentration of oversight authority within the Department of Justice
- Removes external checks provided by the Executive Council
- Reliance on internal AG compliance monitoring may be susceptible to administrative bias
Public Health & Safety
Positive outlook
75%
Benefits
- Prioritizes funding for direct clinical and safety initiatives
- Focuses on measurable patient-outcome objectives
- Reduces administrative diversion of health-protection funds
Risks
- Prohibits research funding that could improve long-term public health strategies
- May discourage innovative, long-lead-time public health interventions
- Potential loss of coordination with state-managed public health programs
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
LegiScan
Official bill text or data from LegiScan.
Confidence
High
Information is complete and verified.
Analysis basis
LegiScan full bill text
Source used for this bill's analysis.
Source note
Prohibiting state agencies from acting as subgrantees may disrupt existing multi-agency health service delivery models.
Analysis scope
Fiscal note is based on Department of Justice estimates and is subject to change based on actual proposal volume.
04
Where it stands
Official record- IntroducedComplete
- CommitteeCurrent
- Chamber votesUpcoming
- Final agreementUpcoming
- GovernorUpcoming
- EnactedUpcoming
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.